| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
HPV and/or Cervical Cancer Vaccines
|
NIAID
|
5R37AI038382-14
|
|
HPV CAPSID ANTIBODIES
|
GALLOWAY, DENISE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$316,257
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5R21CA114978-02
|
|
A Therapeutic Vaccine for HPV 16-Positive Head and Neck Cancer
|
GILLISON, MAURA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$265,009
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5R01CA114425-04
|
|
ENHANCING HPV-16 E6-SPECIFIC ANTITUMOR IMMUNITY
|
WU, T.-C.
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$307,116
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5R01CA112512-04
|
|
Immunogenetics of Cervical and Vulvar Cancer
|
SCHWARTZ, STEPHEN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$607,277
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5R01CA105181-04
|
|
Natural History of HPV Infections in Men
|
KOUTSKY, LAURA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$652,646
|
|
HPV and/or Cervical Cancer Vaccines
|
NIAID
|
1R01AI073713-01A2
|
|
Behavioral and Virologic Impact of HPV Immunization
|
KAHN, JESSICA
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$537,672
|
|
HPV and/or Cervical Cancer Vaccines
|
NIAID
|
5R01AI038383-14
|
|
Acquisition and Natural History of Genital HPV Infection
|
KOUTSKY, LAURA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$630,644
|
|
HPV and/or Cervical Cancer Vaccines
|
NIAID
|
5R41AI068159-02
|
|
Antiviral Compounds that Target HPV18 DNA
|
FISHER, CHRISTOPHER
|
NANOVIR, LLC.
|
MI
|
$498,425
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1R21CA128232-01A1
|
|
Therapeutic HPV vaccination for stage IB1 cervical cancer
|
TRIMBLE, CORNELIA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$294,156
|
|
HPV and/or Cervical Cancer Vaccines
|
NIAID
|
5R01AI072204-02
|
|
Cervical, Anal, and Oral HPV Persistence and Risk Factors Among Adolescent Girls
|
DIAZ, ANGELA
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$818,235
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5R01CA047622-17
|
|
Papillomavirus Host Interaction
|
CHRISTENSEN, NEIL
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$303,123
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1R01CA133749-01
|
|
A Phase I Study to Evaluate the Safety and Immunogenicity of HPV 16 L2 11-200
|
HUH, WARNER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$411,728
|
|
HPV and/or Cervical Cancer Vaccines
|
FIC
|
5R03TW007662-03
|
|
Men & Women's Social-Cultural Factors Assoc w/Cervical Cancer Prevention in Panam
|
GIULIANO, ANNA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$34,577
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5R01CA069632-10
|
|
Cancer immunotherapy with a live recombinant vaccine
|
PATERSON, YVONNE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$326,923
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
3U01CA114604-04S1
|
|
Formative Research on Latinos and Leaders on HPV Vaccine Acceptance and Promotion
|
ESPINOZA, PAULA
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$77,000
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5K07CA113773-03
|
|
An interdisciplinary use of models for cancer prevention
|
KULASINGAM, SHALINI
|
DUKE UNIVERSITY
|
NC
|
$103,518
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
3U01CA114644-04S2
|
|
Communication Inequalities on HPV, Cervical Cancer, and the HPV Vaccine
|
KOH, HOWARD
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$80,117
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
3U01CA114633-04S2
|
|
Radionovela to address cervical cancer and the HPV vaccine for rural Hispanics
|
THOMPSON, BETI
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$82,342
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
3U01CA114594-04S2
|
|
African American Attitudes Toward HPV Vaccination
|
COLDITZ, GRAHAM
|
WASHINGTON UNIVERSITY
|
MO
|
$74,577
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5R01CA118790-02
|
|
Mechanisms of Papillomavirus Neutralization
|
RODEN, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$280,440
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5K07CA120040-02
|
|
Mass Spectroscopy-based HPV Detection in Cervical Cancer Screening
|
PATEL, DIVYA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$135,681
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
2U01CA078527-11
|
|
Persistent HPV in Women at Risk for Cervix Cancer
|
BURK, ROBERT
|
YESHIVA UNIVERSITY
|
NY
|
$527,561
|
|
HPV and/or Cervical Cancer Vaccines
|
NIDCR
|
1R01DE019075-01
|
|
Develop an Oral HIV Vaccine Using Papilloma Virus-Like Particles as a Vector
|
QIAO, LIANG
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$372,384
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5R03CA130724-02
|
|
Translating an Efficaious HPV Vaccine into the Control of Cervical Cancer
|
BOND, SHARON
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$76,155
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1R21CA134259-01
|
|
Participatory Research to Understand the Translation of HPV Vaccine Policy
|
SUSSMAN, ANDREW
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$77,500
|
|
HPV and/or Cervical Cancer Vaccines
|
OD
|
1R21CA134259-01
|
|
Participatory Research to Understand the Translation of HPV Vaccine Policy
|
SUSSMAN, ANDREW
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$125,000
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5R01CA125069-02
|
|
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
|
FANG, CAROLYN
|
FOX CHASE CANCER CENTER
|
PA
|
$581,315
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5R44CA089772-05
|
|
A-007: Immune Modulation of HPV - Associated Neoplasia
|
NGUYEN, BINH
|
TIGRIS PHARMACEUTICALS, INC.
|
FL
|
$718,126
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5R01CA093435-05
|
|
Clinical & Cost Effectiveness of HPV Vaccination in the US
|
GOLDIE, SUE
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$373,147
|
|
HPV and/or Cervical Cancer Vaccines
|
NIDCR
|
5F31DE019028-02
|
|
Role of MicroRNAs in Human Papillomavirus-Associated Cancers
|
GARDINER, AMY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$35,930
|
|
HPV and/or Cervical Cancer Vaccines
|
NIAID
|
1R01AI076440-01A1
|
|
Recommendation of HPV Vaccination among U.S. Physicians
|
VADAPARAMPIL, SUSAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$578,307
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1R03CA130747-01A1
|
|
Decision-Making about Childhood HPV Vaccination among Low SES Mothers
|
FLOYD, TIFFANY
|
CITY COLLEGE OF NEW YORK
|
NY
|
$88,874
|
|
HPV and/or Cervical Cancer Vaccines
|
NIAID
|
2R44AI071618-02
|
|
ApoVax104-HPV as a Novel Vaccine for Cervical Cancer
|
MACLEOD, KATHRYN
|
APOIMMUNE, INC
|
KY
|
$919,441
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
4R44CA128858-02
|
|
Rapid Point-of-Care Assay for detecting High Risk Human Papillomavirus
|
DOLINGER, DAVID
|
IQUUM, INC.
|
MA
|
$749,896
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1K07CA133099-01A1
|
|
Predictors of HPV16 Status and Outcomes of Oropharyngeal Cancer Patients
|
LI, GUOJUN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$136,080
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1R43CA136357-01A1
|
|
Multivalent HPV Capsomere Vaccines
|
LIVENGOOD, JILL
|
INVIRAGEN, LLC
|
CO
|
$373,315
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1R03CA138069-01
|
|
Using Message Framing to Promote HPV Vaccination
|
GEREND, MARY
|
FLORIDA STATE UNIVERSITY
|
FL
|
$72,560
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5P01CA077839-10
|
0006
|
COX-2: A Target for the Prevention of Cervical Cancer
|
DANNENBERG, ANDREW
|
VANDERBILT UNIVERSITY
|
TN
|
$464,357
|
|
HPV and/or Cervical Cancer Vaccines
|
NIDCR
|
7R01DE018386-03
|
|
Mechanisms of invasion for an HIV related head and neck cancer
|
LEE, JOHN
|
SANFORD RESEARCH/USD
|
SD
|
$410,435
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
5P50DE019032-07
|
0003
|
HPV VACCINE THERAPY AND CORRELATES OF RESPONSE IN HEAD AND NECK SQUAMOUS CELL
|
PAI, SARA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$150
|
|
HPV and/or Cervical Cancer Vaccines
|
NIDCR
|
5P50DE019032-07
|
0003
|
HPV VACCINE THERAPY AND CORRELATES OF RESPONSE IN HEAD AND NECK SQUAMOUS CELL
|
PAI, SARA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$352,507
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
3P50CA098252-05S1
|
|
SPORE in Cervical Cancer
|
WU, T.-C.
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$1,165,045
|
|
HPV and/or Cervical Cancer Vaccines
|
NIAID
|
5U19AI062150-05
|
0002
|
Mucosally Targeted Plant Based STI Vaccine
|
MASON, HUGH
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$349,576
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
3R01CA069632-10S1
|
|
Cancer immunotherapy with a live recombinant vaccine
|
PATERSON, YVONNE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$41,786
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
3R01CA105181-04S1
|
|
Natural History of HPV Infections in Men
|
KOUTSKY, LAURA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$30,475
|
|
HPV and/or Cervical Cancer Vaccines
|
NCRR
|
5M01RR016500-07
|
8179
|
CLINICAL TRIAL: MAGE-A3/HPV16 PEPTIDE IMMUNOTHERAPEUTIC VACCINES FOR SQUAMOUS CE
|
STROME, SCOTT
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$11,581
|
|
HPV and/or Cervical Cancer Vaccines
|
NCRR
|
5M01RR000096-47
|
8557
|
CLINICAL TRIAL: PACTG P1047: QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINE IN HIV-IN
|
BORKOWSKY, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$15,927
|
|
HPV and/or Cervical Cancer Vaccines
|
NCRR
|
5P20RR011126-14
|
6705
|
DETECTION OF HPV INFECTION IN THE ANOGENITAL AREA
|
ORTIZ, ANA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
PR
|
$29,901
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1Z01BC009052-19
|
|
Papillomavirus Virion Proteins and Vaccines
|
SCHILLER, JOHN
|
NIH
|
|
$1,351,543
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1Z01BC010579-05
|
|
Papillomavirus Virion Proteins and Vaccines
|
LOWY, DOUGLAS
|
NIH
|
|
$764,819
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1Z01BC010756-03
|
|
Development a combined prophylactic and therapeutic cervical cancer vaccine u
|
KHLEIF, SAMIR
|
NIH
|
|
$290,219
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1Z01BC010907-01
|
|
Papillomavirus Infectious Entry
|
BUCK, CHRISTOPHER
|
NIH
|
|
$318,263
|
|
HPV and/or Cervical Cancer Vaccines
|
NCI
|
1Z01CP010177-08
|
|
HPV Vaccine Trials
|
HILDESHEIM, ALLAN
|
NIH
|
|
$499,554
|
